Cancer :: Tony Clement on Canadian Strategy for Cancer Control

The Honourable Tony Clement, Canadian Health Minister, congratulated the new Chair and the rest of the Board of Directors of the new Canadian Partnership Against Cancer Corporation, as they held their second Board meeting.

“I am very pleased by the calibre of individuals who have agreed to serve on the Board of Directors for the Canadian Partnership Against Cancer Corporation,” said Minister Clement, following his meeting with the Board. “As the Board of Directors, you have a tremendous challenge in front you. But it is also an opportunity to rally the strength and experience of everyone involved in the fight against cancer, to save and improve many lives across Canada.”

Thirty-nine per cent of Canadian women and 44 per cent of men will develop cancer in their lifetime, and one in four will die. Canada’s New Government has recognized the importance of a national focal point and national strategy on cancer for Canadians, which led to Prime Minister Stephen Harper’s announcement in November 2006 establishing the Canadian Partnership Against Cancer Corporation to implement the Canadian Strategy for Cancer Control (CSCC). Budget 2006 allocated $260 million over five years to implement the CSCC.

“We’re excited to begin implementation of the Canadian Strategy for Cancer Control,” said Jeffrey C. Lozon, chair of the Board of Directors. “There is much work to be done, and we are already well into our planning process. We will accelerate action on fighting cancer in Canada. We have an outstanding inaugural board ready to take on the task.”

The Partnership is designed to get the very best out of our knowledge today to plan for and improve prevention, diagnosis and treatment tomorrow. It is important that every Canadian has access to the newest and best information on cancer treatment, no matter where they live.

The Canadian Partnership Against Cancer brings together key players to benefit from work they are carrying out in primary prevention; screening/early detection; surveillance; diagnostic and treatment standards; clinical practice guidelines; research; health human resources; and patient-centred care.

Leave a Comment